Breaking Bank of England Holds Key Interest Rate Steady for Fifth Time Venezuelan Acting President Discusses Post-Maduro Vision in TIME Interview Ebola Outbreak in Eastern Congo Becomes Fastest Growing in History EU Invests 10 Billion Euros in AI Gigafactories to Boost Technological Independence AP-NORC Poll: Majority of Americans Believe War in Iran Not Worth Fighting

Thursday July 30, 2026

Reporter

Nuvectis Pharma, Inc.

2Articles Published

5Communities Covered

Published Articles

Press Release

Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23

Press Release

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23